282524-82-7

Basic information

• Product Name: 3-AMINO-3-(4-TERT-BUTYL-PHENYL)-PROPIONIC ACID
• Synonyms: 3-AMINO-3-(4-TERT-BUTANEPHENYL)PROPANOIC ACID;3-AMINO-3-[4-(TERT-BUTYL)PHENYL]PROPANOIC ACID;3-AMINO-3-(4-TERT-BUTYL-PHENYL)-PROPIONIC ACID;RARECHEM AK HD C009
• CAS NO: 282524-82-7
• Molecular Formula: C₁₃H₁₉NO₂
• Molecular Weight: 221.3
• Product Categories: API intermediates
• Mol File: 282524-82-7.mol
• Article Data: 6

Chemical Properties

• Melting Point: 240-242°C
• Boiling Point: 352.2°Cat760mmHg
• Flash Point: 166.8°C
• Appearance: /
• Density: 1.082g/cm³
• Vapor Pressure: 1.45E-05mmHg at 25°C
• Refractive Index: 1.537
• PKA: 3.72±0.10(Predicted)
• CAS DataBase Reference: 3-AMINO-3-(4-TERT-BUTYL-PHENYL)-PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-AMINO-3-(4-TERT-BUTYL-PHENYL)-PROPIONIC ACID(282524-82-7)
• EPA Substance Registry System: 3-AMINO-3-(4-TERT-BUTYL-PHENYL)-PROPIONIC ACID(282524-82-7)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 282524-82-7(Hazardous Substances Data)

Usage

General Description

3-Amino-3-(4-tert-butyl-phenyl)-propionic acid is a complex, organic chemical compound. As the name suggests, it is an amino acid, which means it is a building block of proteins and plays a crucial role in biological functions. The structure consists of an amino group, a carboxyl group, and a specific side chain featuring a 4-tert-butyl-phenyl group, which gives the compound its unique properties. Its presence of a tert-butyl group indicates that it is a derivative of butane. Despite its complicated name, like other amino acids, it participates in the formation of proteins, which makes it a significant aspect of biochemistry and field of pharmacology. Exact usage and effects of this chemical are dependent on the context and the functions other accompanying compounds or elements.

InChI:InChI=1/C13H19NO2/c1-13(2,3)10-6-4-9(5-7-10)11(14)8-12(15)16/h4-7,11H,8,14H2,1-3H3,(H,15,16)

Upstream product

• 98708-80-6 4'-tert-butyl-(RS)-α-phenylalanine 
• 141-82-2 malonic acid 
• 939-97-9 4-tert-Butylbenzaldehyde 

Downstream Products

• 496912-08-4 3-amino-3-(4-tert-butyl-phenyl)-propionic acid ethyl ester 
• 618109-81-2 methyl 3-amino-3-(4-(tert-butyl)phenyl)propanoate 

Relevant articles and documents

Preparation and application of novel eEF2K depressant

The invention relates to preparation and application of an eEF2K depressant and belongs to the technical field of antitumor pharmacy. A technical problem to be solved by the invention is to provide acompound as the eEF2K depressant. The compound comprises a compound represented by a formula shown in the description or pharmaceutically acceptable salts thereof. The compound or pharmaceutically acceptable salts thereof can serve as the eEF2K depressant, have certain anti-tumor activity and can effectively depress the growth of cancer cells. The compound disclosed by the invention has an obviousdepression action on a variety of tumor cells, particularly three-negative mammary cancer cells.

Synthesis and biological evaluation of 3-phenyl-3-aryl carboxamido propanoic acid derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26A1)

All-trans-retinoic acid (ATRA), the biologically active metabolite of vitamin A, is used medicinally for the treatment of hyperproliferative diseases and cancers. However, it is easily metabolized. In this study, the leading compound S8 was found based on virtual screening. To improve the activity of the leading compound S8, a series of novel S8 derivatives were designed, synthesized and evaluated for their in vitro biological activities. All of the prepared compounds showed that substituting the 5-chloro-3-methyl-1-phenyl-1H-pyrazole group for the 2-tertbutyl-5-methylfuran scaffold led to a clear increase in the biological activity. The most promising compound 32, with a CYP26A1 IC50 value of 1.36 μM (compared to liarozole (IC50 = 2.45 μM) and S8 (IC50 = 3.21 μM)) displayed strong inhibitory and differentiation activity against HL60 cells. In addition, the study focused on the effect of β-phenylalanine, which forms the coordination bond with the heme of CYP26A1. These studies suggest that the compound 32 can be used as an appropriate candidate for future development.

PROCESS FOR THE PREPARATION OF β-AMINOCARBOXYLIC ACIDS

The present invention relates to a method of producing β-aminocarboxylic acids or their derivatives by conversion of compounds of formula (I) with ketene acetals in the presence of a base.